Key Takeaways:
Powered by lumidawealth.com
- CVS is launching 12 smaller stores focused on pharmacy services, cutting back on traditional retail offerings.
- The move reflects a response to declining retail sales, competition from online and discount retailers, and rising theft.
- CVS plans to close 270 locations in 2025, continuing its downsizing trend from previous years.
- The new format targets underserved communities with limited pharmacy access, while maintaining a focus on prescription sales, which account for over 80% of revenue.
What Happened?
CVS Health is introducing a new store format with smaller locations averaging less than 5,000 square feet—less than half the size of a typical CVS. These stores will focus on full-service pharmacies and health-related products, such as over-the-counter medications, while eliminating traditional retail items like groceries and beauty products. This shift comes as CVS and other drugstore chains face declining retail sales, competition from online and discount retailers, and increased theft. CVS is also continuing its broader downsizing strategy, with plans to close 270 locations in 2025, following 800 closures over the past three years.
Why It Matters?
This strategic pivot underscores CVS’s recognition that its core value lies in pharmacy services, which generated over 80% of its sales last year. By focusing on prescriptions and health-related products, CVS aims to strengthen its position in a competitive market increasingly dominated by online and discount retailers. The downsizing and shift to smaller stores also reflect cost-cutting measures to address declining margins and operational challenges, such as theft and changing consumer behavior. For investors, this move signals a focus on profitability and efficiency, as CVS adapts to a rapidly evolving retail landscape.
What’s Next?
CVS plans to roll out the first of these smaller stores by the end of 2025, targeting underserved communities with limited pharmacy access. The company will also open 30 traditional stores, including pharmacies within Target locations, to maintain a diverse footprint. Investors should monitor the performance of these new formats, particularly in terms of customer adoption and profitability, as well as CVS’s ability to compete with online and discount retailers. Additionally, the broader implications of downsizing and market consolidation in the pharmacy sector, including Walgreens’ recent leveraged buyout and Rite Aid’s restructuring, will shape the competitive landscape moving forward.
